BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rai N, Shihan M, Seeger W, Schermuly RT, Novoyatleva T. Genetic Delivery and Gene Therapy in Pulmonary Hypertension. Int J Mol Sci 2021;22:1179. [PMID: 33503992 DOI: 10.3390/ijms22031179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Reschke M, Piotrowski-Daspit AS, Pober JS, Saltzman WM. Nucleic Acid Delivery to the Vascular Endothelium. Mol Pharm 2022;19:4466-86. [PMID: 36251765 DOI: 10.1021/acs.molpharmaceut.2c00653] [Reference Citation Analysis]
2 Dai L, Du L. Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy. Front Genet 2022;13:961848. [PMID: 36506323 DOI: 10.3389/fgene.2022.961848] [Reference Citation Analysis]
3 Ainscough AJ, Smith TJ, Haensel M, Rhodes CJ, Fellows A, Whitwell HJ, Vasilaki E, Gray K, Freeman A, Howard LS, Wharton J, Dunmore B, Upton PD, Wilkins MR, Edel JB, Wojciak-stothard B. An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis. Commun Biol 2022;5:1192. [DOI: 10.1038/s42003-022-04169-z] [Reference Citation Analysis]
4 Katz MG, Hadas Y, Vincek A, Freage-kahn L, Shtraizent N, Madjarov JM, Pastuszko P, Eliyahu E. Acid Ceramidase Gene Therapy Ameliorates Pulmonary Arterial Hypertension with Right Heart Dysfunction.. [DOI: 10.21203/rs.3.rs-1910406/v1] [Reference Citation Analysis]
5 Hu Y, Jin L, Pan Y, Zou J, Wang Z. Apela gene therapy alleviates pulmonary hypertension in rats. FASEB J 2022;36:e22431. [PMID: 35747913 DOI: 10.1096/fj.202200266R] [Reference Citation Analysis]
6 Dhoble S, Patravale V, Weaver E, Lamprou DA, Patravale T. Comprehensive Review on Novel Targets and Emerging Therapeutic Modalities for Pulmonary Arterial Hypertension. Int J Pharm 2022;:121792. [PMID: 35513217 DOI: 10.1016/j.ijpharm.2022.121792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bikou O, Ishikawa K. Endobronchial Gene Delivery for Pulmonary Hypertension in a Large Animal Model. Methods Mol Biol 2022;2573:279-89. [PMID: 36040602 DOI: 10.1007/978-1-0716-2707-5_21] [Reference Citation Analysis]
8 Bisserier M, Katz MG, Bueno-Beti C, Brojakowska A, Zhang S, Gubara S, Kohlbrenner E, Fazal S, Fargnoli A, Dorfmuller P, Humbert M, Hata A, Goukassian DA, Sassi Y, Hadri L. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension. Int J Mol Sci 2021;22:9105. [PMID: 34502015 DOI: 10.3390/ijms22179105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]